Postsynaptic 5-HT1A receptors mediate an increase in locomotor activity in the monoamine-depleted rat

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Psychopharmacology

• Publication date

  2002-07-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00213-002-1121-3PMID 12185404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long lasting supersensitivity to 5-HT mediated behaviour following monoamine depletion in the rat brain.

  2009cited by this paper
• Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats

  2005cited by this paper
• Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats

  2005cited by this paper
• Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease

  2005cited by this paper
• The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity

  2005cited by this paper
• Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens

  2004influential reference
• Serotonin depletion produces long lasting increase in striatal glutamatergic transmission

  2001cited by this paper
• Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat.

  1999cited by this paper
• Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.

  1999influential reference
• Excitatory amino acids as neurotransmitters of corticostriatal projections: immunocytochemical evidence in the rat.

  1998cited by this paper
• Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease.

  1997cited by this paper
• Interactions of (+)- and (−)-8- and 7-Hydroxy-2-(Di-n-Propylamino)tetralin at Human (h)D3, hD2 and h Serotonin1A Receptors and Their Modulation of the Activity of Serotoninergic and Dopaminergic Neurones in Rats

  1997influential reference
• Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway?

  1997cited by this paper
• Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment

  1996cited by this paper
• Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

  1996cited by this paper
• Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.

  1996cited by this paper
• Prevention by (±)‐8‐hydroxy‐2‐(di‐npropylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol

  1996cited by this paper
• Role of 5-HT1A receptors in the ability of mixed 5-HT1A receptor agonist/dopamine D2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats.

  1996cited by this paper
• Antagonism of reserpine-induced suppression of spontaneous motor activity by stimulation of 5-HT1A receptors in rats.

  1995influential reference
• Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat.

  1995influential reference
• Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease

  1995cited by this paper
• Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain

  1995cited by this paper
• NMDA‐induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5‐HT1A antagonist

  1995cited by this paper
• Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.

  1994cited by this paper
• Depletion and repletion of cortical tissue and dialysate 5-HT after reserpine.

  1994cited by this paper
• Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations

  1994cited by this paper
• Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex.

  1993cited by this paper
• Serotonergic involvement in haloperidol-induced catalepsy.

  1993influential reference
• Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis.

  1993cited by this paper
• Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding

  1992cited by this paper
• 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.

  1992cited by this paper
• 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex.

  1991cited by this paper
• Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.

  1991cited by this paper
• Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.

  1991cited by this paper
• Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat.

  1990influential reference
• Behavioural effects of serotonin agonists and antagonists in the rat and marmoset.

  1990cited by this paper
• The effect of serotonergic agents on haloperidol-induced catalepsy.

  1990cited by this paper
• NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats

  1990cited by this paper
• Effects of 8-OH-DPAT on motor activity in the rat.

  1989influential reference
• An in vivo dialysis and behavioural study of the release of 5‐HT by p‐chloroamphetamine in reserpine‐treated rats

  1989cited by this paper
• alpha-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release.

  1989cited by this paper
• Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.

  1988cited by this paper
• The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo.

  1988cited by this paper
• 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis.

  1988influential reference
• The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo

  1988cited by this paper
• Behavioral Models of Serotonin Receptor Activation

  1988cited by this paper
• 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.

  1985cited by this paper
• Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity?

  1985cited by this paper
• The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

  1984influential reference
• Dopaminergic effects of buspirone, a novel anxiolytic agent.

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• POTENTIATION AND INHIBITION OF SOME CENTRAL ACTIONS OF L(—)-DOPA BY DECARBOXYLASE INHIBITORS

  1970cited by this paper

• Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson’s Disease

  2025cites this paper
• Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges

  2025cites this paper
• Management of serotonin syndrome (toxicity)

  2024cites this paper
• Hypothermia as a Possible Symptom of Serotonin Toxicity: A Case Report.

  2023cites this paper
• Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism

  2022cites this paper
• 8-OH-DPAT enhances dopamine D2-induced maternal disruption in rats

  2022cites this paper
• Antidepressant‐induced serotonin syndrome in older patients: a cross‐sectional study

  2022cites this paper
• The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes

  2021cites this paper
• Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects

  2019cites this paper
• Serotonin Receptors as the Therapeutic Target for Central Nervous System Disorders

  2019cites this paper
• University of Birmingham Serotonin syndrome

  2019cites this paper
• Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions

  2019cites this paper
• Serotonin and feeding regulation

  2019cites this paper
• In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease

  2018cites this paper
• 5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives.

  2018cites this paper
• Multi-Target Approach for Drug Discovery against Schizophrenia

  2018cites this paper
• Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias

  2017cites this paper
• Long-term effects of pre-pubertal fluoxetine on behaviour and monoaminergic stress response in stress-sensitive rats

  2016cites this paper
• A dose–response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity

  2016cites this paper
• Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice.

  2016cites this paper
• Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial.

  2016cites this paper
• Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms.

  2016cites this paper
• 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia.

  2015cites this paper
• New insight into the therapeutic role of the serotonergic system in Parkinson's disease.

  2015cites this paper
• Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.

  2014cites this paper
• Deficits in Striatal Dopamine and Hippocampal Serotonin Following Induction of Anxiety/Depressive-Like Behaviors by Bisphenol A

  2014cites this paper
• Les systèmes monoaminergiques : implication dans la physiopathologie et la thérapie de la maladie de Parkinson

  2014cites this paper
• The long-term effects of fluoxetine on stress-related behaviour and acute monoaminergic stress response in stress sensitive rats

  2014cites this paper
• Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson’s disease

  2014cites this paper
• Pathophysiological roles of serotonergic system in regulating extrapyramidal motor functions.

  2013cites this paper
• Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions.

  2013cites this paper
• Impulsivity and home-cage activity are decreased by lentivirus-mediated silencing of serotonin transporter in the rat hippocampus.

  2013cites this paper
• 5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms.

  2013cites this paper
• Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

  2013cites this paper
• Buspirone: what is it all about?

  2012cites this paper
• 50-kHz calls in rats: effects of MDMA and the 5-HT(1A) receptor agonist 8-OH-DPAT.

  2012cites this paper
• Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors.

  2011cites this paper
• Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.

  2011cites this paper
• Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.

  2011cites this paper
• Potential serotonin 5-HT1A and dopamine D4 receptor modulation of the discriminative stimulus effects of amphetamine in rats

  2011cites this paper
• Therapeutic Role of 5‐HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease

  2011cites this paper
• The serotonergic system in Parkinson's disease.

  2011cites this paper
• A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder.

  2010cites this paper
• Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats

  2010cites this paper
• Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders.

  2010cites this paper
• New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders.

  2010cites this paper
• Anxiogenic and anorexiogenic effects of restraint stress in rats pretreated with buspirone or propranolol

  2010cites this paper
• A diverse development of 5-HT1A receptor binding is relevant to behavioral differences observed in adult mice of two genetically closely related inbred strains.

  2010cites this paper
• Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.

  2009cites this paper
• Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice.

  2009cites this paper
• Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on l-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat

  2008cites this paper
• Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens.

  2008influential citation
• Evaluation of the antibradykinetic actions of 5-HT1A agonists using the mouse pole test.

  2008cites this paper
• Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.

  2008cites this paper
• The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.

  2007cites this paper
• Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson’s disease

  2007influential citation
• Chronic administration of fluoxetine alters locomotor behavior, but does not potentiate the locomotor stimulating effects of CRH in juvenile Chinook salmon (Oncorhynchus tshawytscha).

  2007cites this paper
• Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.

  2007cites this paper
• Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes

  2007cites this paper
• ROLE OF SEROTONIN-1A RECEPTORS IN RESTRAINT-INDUCED BEHAVIORAL DEFICITS AND ADAPTATION TO REPEATED RESTRAINT STRESS IN RATS

  2007cites this paper
• The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.

  2007cites this paper
• The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.

  2007cites this paper
• The effect of the 5-HT1A receptor agonist, 8-OH-DPAT, on motion-induced emesis in Suncus murinus.

  2006cites this paper
• Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT).

  2006cites this paper
• Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.

  2006cites this paper
• Serotonin 1A and 2A receptor densities, neurochemical and behavioural characteristics in two closely related mice strains after long-term isolation.

  2006cites this paper
• Dopamine β-Hydroxylase Knockout Mice have Alterations in Dopamine Signaling and are Hypersensitive to Cocaine

  2006cites this paper
• MDMA and fenfluramine reduce L‐DOPA‐induced dyskinesia via indirect 5‐HT1A receptor stimulation

  2006cites this paper
• 8-Hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease

  2005cites this paper
• Serotonergic mechanisms in Parkinson’s disease: opposing results from preclinical and clinical data

  2005cites this paper
• Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.

  2005cites this paper
• The Pathophysiology of Serotonin Toxicity in Animals and Humans: Implications for Diagnosis and Treatment

  2005cites this paper
• Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.

  2004cites this paper
• Gross mapping of α1-adrenoceptors that regulate behavioral activation in the mouse brain

  2004cites this paper
• The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior

  2004cites this paper
• Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat

  2003cites this paper
• The L-DOPA-sparing effect of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride [(-)-BPAP] in reserpine-pretreated rats.

  2003cites this paper
• Evidence that acute serotonergic activation potentiates the locomotor-stimulating effects of corticotropin-releasing hormone in juvenile chinook salmon (Oncorhynchus tshawytscha).

  2003cites this paper